Aspire Bio Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 5009.63%
(FY 2022)
- Profit 4649.72%
(FY 2022)
- Ebitda -4193.76%
(FY 2022)
- Net Worth 863.41%
(FY 2022)
- Total Assets 2363.24%
(FY 2022)
About Aspire Bio Pharma India
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Riyas Thiruthimmel and Kaithakkal Faseela serve as directors at the Company.
- CIN/LLPIN
U52100KL2020PTC064076
- Company No.
064076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aspire Bio Pharma India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Riyas Thiruthimmel  | Director | 03-Sep-2020 | Current |
| Kaithakkal Faseela | Director | 03-Sep-2020 | Current |
Financial Performance of Aspire Bio Pharma India.
Aspire Bio Pharma India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 5009.63% increase. The company also saw a substantial improvement in profitability, with a 4649.72% increase in profit. The company's net worth Soared by an impressive increase of 863.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspire Bio Pharma India?
Unlock access to Aspire Bio Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biorex Super Speciality Private LimitedActive 2 years 6 monthsRiyas Thiruthimmel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aspire Bio Pharma India?
Aspire Bio Pharma India has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspire Bio Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspire Bio Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
